Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Subtle Medical has achieved nine FDA clearances for its suite of deep learning–powered software tools that enhance the speed and quality of PET/MRI scans. Its flagship products—SubtleMR™, SubtlePET™, and the newly cleared SubtleSynth™—are used clinically worldwide to reduce scan times by up to fourfold while maintaining or improving diagnostic accuracy. Clinical studies have demonstrated improved patient throughput without compromising safety or efficacy. The company’s pipeline includes further innovations such as gadolinium dose-reduction technology for safer MRI exams.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Subtle Medical.